BIO-RAD LABORATORIES, INC.Bio-Rad Laboratories, Inc. • March 2nd, 2022 • Laboratory analytical instruments
THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE FIRST SUPPLEMENTAL INDENTURE GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (I) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 3.02 OF THE FIRST SUPPLEMENTAL INDENTURE, (II) THIS GLOBAL NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 3.02(a) OF THE FIRST SUPPLEMENTAL INDENTURE, (III) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.12 OF THE BASE INDENTURE AND (IV) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY.
BIO-RAD LABORATORIES, INC. as Issuer and WILMINGTON TRUST, NATIONAL ASSOCIATION as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of March 2, 2022 to the Indenture dated as of March 2, 2022 3.300% Senior Notes due 2027 3.700% Senior Notes due 2032Bio-Rad Laboratories, Inc. • March 2nd, 2022 • Laboratory analytical instruments • New York
FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of March 2, 2022, between BIO-RAD LABORATORIES, INC., a Delaware corporation (the “Company”), and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee (the “Trustee”).
Bio-Rad Laboratories, Inc. $400,000,000 3.300% Senior Notes due 2027 $800,000,000 3.700% Senior Notes due 2032 UNDERWRITING AGREEMENTUnderwriting Agreement • March 2nd, 2022 • Bio-Rad Laboratories, Inc. • Laboratory analytical instruments • New York
